Suvretta Capital Management, LLC 13D and 13G filings for ArriVent BioPharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-13 7:29 pm Purchase | 2025-06-30 | 13G | ARRIVENT BIOPHARMA INC AVBP | Suvretta Capital Management, LLC | 3,412,788 9.900% | 1,372,423 (+67.26%) | Filing |
| 2024-12-04 4:32 pm Purchase | 2024-11-26 | 13G | ARRIVENT BIOPHARMA INC AVBP | Suvretta Capital Management, LLC | 2,040,365 6.100% | 2,040,365 (New Position) | Filing |